Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study

Journal of Neurology Neurosurgery & Psychiatry ◽

10.1136/jnnp.66.4.436 ◽

1999 ◽

Vol 66 (4) ◽

pp. 436-441 ◽

Author(s):

M M Pinter ◽

O Pogarell ◽

W H Oertel

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Multicentre Study ◽

Dopamine Agonist ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Double Blind Placebo

Download Full-text

Clinical evaluation of pramipexole in advanced Parkinson's disease: Results of a double-blind, placebo-controlled, parallel-group study

Neurology ◽

10.1212/wnl.49.1.162 ◽

1997 ◽

Vol 49 (1) ◽

pp. 162-168 ◽

Author(s):

A. Lieberman ◽

A. Ranhosky ◽

D. Korts

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Clinical Evaluation ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Double Blind Placebo ◽

Parallel Group Study ◽

Download Full-text

Pramipexole in patients with Parkinson's disease and marked drug resistant tremor: a randomised, double blind, placebo controlled multicentre study

Journal of Neurology Neurosurgery & Psychiatry ◽

10.1136/jnnp.72.6.713 ◽

2002 ◽

Vol 72 (6) ◽

pp. 713-720 ◽

Author(s):

O Pogarell

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Multicentre Study ◽

Drug Resistant ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A double-blind, placebo-controlled, randomized, multi-center study of pramipexole in advanced Parkinson's disease

European Journal of Neurology ◽

10.1046/j.1468-1331.1998.530235.x ◽

1998 ◽

Vol 5 (3) ◽

pp. 235-242 ◽

Author(s):

L. Wermuth ◽

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Double Blind Placebo ◽

Multi Center Study ◽

Download Full-text

2.209 Long-term double-blind, placebo-controlled evaluation of the safety and efficacy of safinamide as an add-on to stable dopamine agonist therapy in patients with Parkinson's disease

Parkinsonism & Related Disorders ◽

10.1016/s1353-8020(08)70620-5 ◽

2007 ◽

Vol 13 ◽

pp. S99-S100 ◽

Author(s):

R. Anand ◽

V. Lucini ◽

R. Guiliani ◽

S. Rossetti

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Dopamine Agonist ◽

Agonist Therapy ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Dopamine Agonist Therapy ◽

Controlled Evaluation

Download Full-text

Rotigotine transdermal patch in Chinese patients with advanced Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study

Parkinsonism & Related Disorders ◽

10.1016/j.parkreldis.2017.08.015 ◽

2017 ◽

Vol 44 ◽

pp. 6-12 ◽

Author(s):

Zhen-Xin Zhang ◽

Chun-Feng Liu ◽

En-Xiang Tao ◽

Ming Shao ◽

Yi-Ming Liu ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Chinese Patients ◽

Transdermal Patch ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Double Blind Placebo ◽

Pivotal Study ◽

Rotigotine Transdermal Patch

Download Full-text

Subcutaneous apomorphine in patients with advanced Parkinson's disease: A dose-escalation study with randomized, double-blind, placebo-controlled crossover evaluation of a single dose

Journal of the Neurological Sciences ◽

10.1016/j.jns.2007.03.013 ◽

2007 ◽

Vol 258 (1-2) ◽

pp. 137-143 ◽

Author(s):

Rajesh Pahwa ◽

William C. Koller ◽

Richard M. Trosch ◽

James H. Sherry

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Single Dose ◽

Dose Escalation ◽

Dose Escalation Study ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Double Blind Placebo ◽

Subcutaneous Apomorphine

Download Full-text

Transdermal rotigotine in advanced Parkinson’s disease: a randomized, double-blind, placebo-controlled trial

Journal of Neurology ◽

10.1007/s00415-014-7427-3 ◽

2014 ◽

Vol 261 (10) ◽

pp. 1887-1893 ◽

Author(s):

Masahiro Nomoto ◽

Yoshikuni Mizuno ◽

Tomoyoshi Kondo ◽

Kazuko Hasegawa ◽

Miho Murata ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Controlled Trial ◽

Double Blind ◽

Advanced Parkinson’S Disease ◽

Double Blind Placebo

Download Full-text

Efficacy and tolerability of entacapone in patients with Parkinson's disease treated with levodopa plus a dopamine agonist and experiencing wearing-off motor fluctuations. A randomized, double-blind, multicentre study

Journal of Neural Transmission ◽

10.1007/s00702-002-0799-z ◽

2003 ◽

Vol 110 (3) ◽

pp. 239-251 ◽

Author(s):

G. F�nelon ◽

S. Gim�nez-Rold�n ◽

J. L. Montastruc ◽

F. Bermejo ◽

F. Durif ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Multicentre Study ◽

Dopamine Agonist ◽

Motor Fluctuations ◽

Double Blind ◽

Download Full-text

Faculty Opinions recommendation of Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.737065221.793569342 ◽

2020 ◽

Author(s):

Joseph Jankovic ◽

Arjun Tarakad

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.8286956.8718054 ◽

2011 ◽

Author(s):

Irene Litvan ◽

Rita Simoes

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Depressive Symptoms ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo

Download Full-text